US 11,666,644 B2
Peptide vaccines
Julianna Lisziewicz, Balatonalmádi (HU); Levente Molnar, Felsopakony (HU); Eniko Toke, Felsopakony (HU); József Toth, Gyor (HU); Orsolya Lorincz, Budapest (HU); Zsolt Csiszovszki, Budapest (HU); Eszter Somogyi, Balatonalmádi (HU); Katalin Pantya, Budapest (HU); and Mónika Megyesi, Mezokeresztes (HU)
Assigned to Treos Bio Limited, London (GB)
Appl. No. 17/250,725
Filed by TREOS BIO LIMITED, London (GB)
PCT Filed Sep. 3, 2019, PCT No. PCT/EP2019/073476
§ 371(c)(1), (2) Date Feb. 24, 2021,
PCT Pub. No. WO2020/048990, PCT Pub. Date Mar. 12, 2020.
Claims priority of application No. 1814364 (GB), filed on Sep. 4, 2018; application No. 1814365 (GB), filed on Sep. 4, 2018; application No. 1814366 (GB), filed on Sep. 4, 2018; and application No. 1814367 (GB), filed on Sep. 4, 2018.
Prior Publication US 2023/0102031 A1, Mar. 30, 2023
Int. Cl. A61K 39/00 (2006.01); A61P 35/00 (2006.01); A61P 1/00 (2006.01); A61K 45/06 (2006.01)
CPC A61K 39/0011 (2013.01) [A61K 39/00115 (2018.08); A61K 39/001184 (2018.08); A61K 39/001186 (2018.08); A61K 39/001189 (2018.08); A61K 45/06 (2013.01); A61P 1/00 (2018.01); A61P 35/00 (2018.01); A61K 2039/545 (2013.01); A61K 2039/70 (2013.01); A61K 2039/828 (2018.08)] 23 Claims
 
1. A composition comprising: (i) a peptide having an amino acid sequence comprising any one of the sequences set forth in SEQ ID NOs: 61-75; and (ii) an adjuvant.